The aim of the study was to analyze the effects of anti-thymocyte globulin (ATG) induction therapy on rejection, renalfunction, infection, tumor rate, and survival.
Preterm delivery was associated with maternal drug-treated hypertension and impaired renalfunction. A matched case-control study showed no evidence of increased renal allograft loss after pregnancy.